Xin Ning, Wei Rongqiang, Huang Kenan, Chen Zihao, Liu Chengdong, Fang Yunhao, Xu Zhifei, Ding Xinyu, Tang Hua
Department of Thoracic Surgery, Shanghai Changzheng Hospital, Navy Military Medical University, Shanghai, China.
J Gastrointest Oncol. 2021 Aug;12(4):1277-1284. doi: 10.21037/jgo-21-441.
To evaluate the safety and efficacy of single incision plus one (SI+1) port three-dimensional (3D) laparoscopic minimally invasive esophagectomy (MIE).
Clinical data of patients who underwent 3D thoracic laparoscopic MIE in our department from September 2020 to March 2021 were analyzed retrospectively. According to the different methods of laparoscopic surgery, the patients were divided into 2 groups: SI+1 port 3D laparoscopy group and multiportal 3D laparoscopy group. The operation time of the 3D laparoscopy component, amount of intraoperative blood loss, number of celiac lymph node dissections, postoperative abdominal drainage days, postoperative total abdominal drainage, postoperative complications, and length of hospital stay were analyzed.
There was no significant difference between the 2 methods in laparoscopic operation time (30.11±5.86 28.45±4.72 min, P=0.49), intraoperative blood loss (34.44±9.82 35.91±6.25 mL, P=0.69), number of celiac lymph node dissections (8.44±3.13 7.09±2.12, P=0.27), postoperative abdominal drainage days (3.11±0.33 3.00±0.00 days, P=0.28), postoperative total abdominal drainage (95.00±23.33 92.27±11.26 mL, P=0.74), postoperative complications (22.2% 27.3%, P=0.33), and hospital stay (9.67±0.71 10.18±0.87 days, P=0.17). None of the patients enrolled in the study had recurrence or death to date.
The application of SI+1 port 3D laparoscopy in minimally invasive resection of esophageal carcinoma is safe and feasible.
评估单切口加单孔(SI+1)三端口三维(3D)腹腔镜微创食管癌切除术(MIE)的安全性和有效性。
回顾性分析2020年9月至2021年3月在我科接受3D胸腔镜MIE的患者的临床资料。根据腹腔镜手术方式的不同,将患者分为两组:SI+1端口3D腹腔镜组和多端口3D腹腔镜组。分析3D腹腔镜部分的手术时间、术中出血量、腹腔淋巴结清扫数目、术后腹腔引流天数、术后腹腔总引流量、术后并发症及住院时间。
两种方法在腹腔镜手术时间(30.11±5.86对28.45±4.72分钟,P=0.49)、术中出血量(34.44±9.82对35.91±6.25毫升,P=0.69)、腹腔淋巴结清扫数目(8.44±3.13对7.09±2.12,P=0.27)、术后腹腔引流天数(3.11±0.33对3.00±0.00天,P=0.28)、术后腹腔总引流量(95.00±23.33对92.27±11.26毫升,P=0.74)、术后并发症(22.2%对27.3%,P=0.33)及住院时间(9.67±0.71对10.18±0.87天,P=0.17)方面均无显著差异。截至目前,本研究纳入的患者均无复发或死亡。
SI+1端口3D腹腔镜应用于食管癌微创切除安全可行。